Almirall and Microsoft partner for dermatological drug development
Pharmaceutical Technology
FEBRUARY 1, 2024
Almirall has entered a strategic collaboration with Microsoft to steer innovation and digital transformation in dermatology.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
Pharmaceutical Technology
FEBRUARY 1, 2024
Almirall has entered a strategic collaboration with Microsoft to steer innovation and digital transformation in dermatology.
Pharmaceutical Technology
NOVEMBER 15, 2023
Almirall has entered into a collaboration with Absci for the development and commercialisation of new treatments for dermatological ailments.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
FEBRUARY 1, 2024
Almirall has formed a three-year alliance with Microsoft designed to accelerate the discovery and development of personalised dermatology therapies.
Fierce Pharma
DECEMBER 15, 2023
About a year after Arcutis Biotherapeutics unveiled positive data on roflumilast foam at the European Academy of Dermatology and Venereology congress 2022, the company has clinched a second FDA OK.
BioPharma Reporter
DECEMBER 14, 2023
UK-based Lindus Health and US-based Thirty Madison today (December 14) announced they have completed the enrolment of a trial to assess their personalized dermatology telemedicine platform, Facet.
Drug Discovery World
FEBRUARY 15, 2024
Alys believes that emerging indications such as atopic dermatitis, vitiligo, alopecia areata and chronic spontaneous urticaria, will see the next breakthroughs in dermatological advancements. Alys Pharmaceuticals has launched with an R&D pipeline enabled by multiple platform technologies and a $100 million financing by Medicxi.
pharmaphorum
AUGUST 23, 2023
Leo builds dermatology pipeline with Timber deal Phil.Taylor Wed, 23/08/2023 - 08:40 Bookmark this
Pharmaceutical Technology
MAY 17, 2024
J&J has gained access to several bispecific antibody programmes, including the Phase I-ready asset PX128 for atopic dermatitis and asthma.
pharmaphorum
AUGUST 11, 2023
Strong solutions for increasing dermatology research diversity: Trust me, I’ve got skin in the game Mike.Hammerton Fri, 11/08/2023 - 08:00 Bookmark this
Bio Pharma Dive
JULY 19, 2022
The cream, known as Opzelura, is now the only treatment approved in the U.S. to repigment skin in patients with the most common form of vitiligo.
Drug Discovery World
MARCH 23, 2023
Aldena Therapeutics, a biotech company that is pioneering siRNA-based therapies for dermatological indications, has updated its immuno-dermatology pipeline, appointed a Scientific Advisory Board (SAB), and announced $30 million financing by Medicxi. appeared first on Drug Discovery World (DDW).
Pharma Mirror
APRIL 8, 2022
BARCELONA, Spain and Dundee, UK, a global biopharmaceutical company focused on skin health, today announced a research collaboration with the University of Dundee, a top-ranked university in the UK in biological sciences, to develop a novel approach against chronic and debilitating dermatology diseases where itch, or pruritus, plays a dominant role.
Medical Xpress
JANUARY 24, 2023
A dermatology program first developed by the University of Missouri in 2015 can bring life-saving diagnoses of skin conditions to communities without adequate dermatologic care.
WCG Clinical
OCTOBER 9, 2023
The dermatology market is embarking on tremendous growth and sponsors need to be ready. Over the last 12 months, dermatology-focused studies have increased by roughly 20%, with top focus areas including psoriasis, atopic dermatitis, and alopecia. This rapid growth brings new challenges. Efficiency and speed are critical.
BioPharma Reporter
FEBRUARY 13, 2024
Alys Pharmaceuticals, an immuno-dermatology focused company, has launched with $100 million financing by Medicxi and an R&D pipeline enabled by multiple platform technologies.
pharmaphorum
NOVEMBER 11, 2021
KNUTSFORD, United Kingdom — Fishawack Health welcomes FIDE, an independent organization providing its clients with insight from clinical key opinion leaders in inflammatory dermatology. Kenneth B Gordon, MD, Professor and Chair of Dermatology at the Medical College of Wisconsin. November 10, 2021, UK.
BioPharma Reporter
AUGUST 22, 2023
LEO Pharma has acquired Timber Pharmaceuticals, in a deal that will add an âattractiveâ late stage asset to its pipeline in medical dermatology, the company said.
WCG Clinical
SEPTEMBER 20, 2023
Welcome to the recorded session of ‘Optimizing Endpoint Assessments for Dermatology Studies.’ In this insightful webinar, we take a deep dive into dermatology trials and discuss how standardizing rater qualification and training can solve common challenges and protect the quality and integrity of endpoint data.
Bio Pharma Dive
OCTOBER 4, 2022
The acquisition, Incyte’s first of an entire company, hands the pharmaceutical company a potentially long lasting treatment for the skin disease vitiligo.
pharmaphorum
OCTOBER 9, 2023
Champion Innovation at the 7th Dermatology Drug Development Summit Mike.Hammerton Mon, 09/10/2023 - 14:39 Bookmark this
pharmaphorum
MAY 9, 2023
4th Dermatology Drug Development Summit Europe Mike.Hammerton Tue, 05/09/2023 - 20:11 Bookmark this
Fierce Pharma
JUNE 20, 2024
Everybody sweats, but for the 10 million people in the U.S. living with primary axillary hyperhidrosis, sweating can take on a whole new meaning. | The med is the first new chemical entity to win FDA approval specifically to treat primary axillary hyperhidrosis, or excessive underarm sweating. It's also Botanix's first approved product.
Pharmaceutical Technology
OCTOBER 25, 2023
The funds will go towards Phase II trials for the company’s two candidates treating seborrheic keratoses and melasma.
Outsourcing Pharma
MAY 23, 2022
With Veeva Link for Key People, LEO Pharma is looking to deepen its efforts to engage with knowledgeable medical professionals in the dermatology community.
Drug Discovery World
MARCH 13, 2023
LEO Pharma and ICON have formed a strategic partnership that will enable LEO to offer clinical trials within medical dermatology that are patient-centric and cost effective. The post LEO partners with ICON to offer patient-centric dermatology trials appeared first on Drug Discovery World (DDW).
Pharmaceutical Technology
MAY 28, 2024
J&J has made its second dermatology deal this month, adding Numab’s bispecific antibody NM26 to its growing atopic dermatitis drug portfolio.
BioTech 365
OCTOBER 22, 2021
Castle Biosciences Presents Data from Suite of Dermatologic Cancer Genomic Tests at Fall Clinical Dermatology Conference 2021 Castle Biosciences Presents Data from Suite of Dermatologic Cancer Genomic Tests at Fall Clinical Dermatology Conference 2021 The Company also highlights the study … Continue reading →
Rethinking Clinical Trials
JUNE 26, 2024
Mirza is chief resident in the Department of Dermatology at the Warren Alpert Medical School of Brown University. Fatima Mirza In this Friday’s PCT Grand Rounds, Fatima Mirza of the Warren Alpert Medical School of Brown University will present “Using ChatGPT to Facilitate Truly Informed Medical Consent.”
Pharmaceutical Technology
MARCH 14, 2024
Almirall has signed a licence agreement to gain the rights for Eloxx Pharmaceuticals’ ZKN-013 for rare dermatological disease indications.
Pharmaceutical Technology
APRIL 15, 2024
Learn how (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid can revolutionize dermatological treatments. Discover the groundbreaking patent by Arena Pharmaceuticals for treating atopic dermatitis with a specific compound in a standard dose.
WCG Clinical
MARCH 30, 2023
Uniform Live Action Training Using InvestigatorSpace Speeds Up Study Start Times In one case, a global pharmaceutical company used WCG’s training solutions to support two dermatology studies they were running.
XTalks
JUNE 2, 2021
In this episode, Ayesha talks about Google’s new AI-based dermatology tool designed to help people identify and research conditions of the skin, hair and nails. Read the full articles here: Google Launches AI-Based Dermatology Assist Tool. WHO Calls for Probe into SARS-CoV-2 Origins as Lab Leak Theories Intensify.
Pharmaceutical Technology
MARCH 11, 2024
Sanofi presented the data as part of a late-breaking session at the American Academy of Dermatology (AAD) 2024 conference in San Diego, US.
BioTech 365
JULY 8, 2021
Melanoma Research Alliance Announces 13 Dermatology Fellowship Award Recipients Melanoma Research Alliance Announces 13 Dermatology Fellowship Award Recipients Initiative Represents MRAs Largest Investment in Prevention and Early Detection WASHINGTON–(BUSINESS WIRE)–The Melanoma Research Alliance, the largest non-profit funder of melanoma (..)
Pharmaceutical Technology
MARCH 13, 2024
The dermatology-centric pharma company is likely set for one of the biggest public listings in Europe since 2022.
Pharma Times
APRIL 12, 2023
The trial will monitor patients across Europe for 24 months as they are treated with tildrakizumab
BioTech 365
JANUARY 14, 2022
Novan Announces Presentation of Two Posters at the 2022 Winter Clinical Dermatology Conference Novan Announces Presentation of Two Posters at the 2022 Winter Clinical Dermatology Conference DURHAM, N.C., 14, 2022 (GLOBE NEWSWIRE) — Novan, Inc. (“the the Company” or “Novan”) … Continue reading →
BioTech 365
DECEMBER 29, 2021
Ellen Turner’s Dermatology Office Celebrates Launch of Audrose Beauty Collection with Vogue100 Dr. Ellen Turner’s Dermatology Office Celebrates Launch of Audrose Beauty Collection with Vogue100 The Dallas-based Skin Care Team Joined Audrose™ Founder Justine Nichole for an Exclusive December … Continue reading →
BioTech 365
MAY 10, 2021
DermTech Presents Mini-Symposia at 2021 Society of Investigational Dermatology Virtual Summit DermTech Presents Mini-Symposia at 2021 Society of Investigational Dermatology Virtual Summit LA JOLLA, Calif.–(BUSINESS –(BUSINESS WIRE)–DermTech, Inc.
BioTech 365
JANUARY 19, 2021
DermTech Chief Scientific Officer Michael Howell Presented at Dermatology Summit 2021 DermTech Chief Scientific Officer Michael Howell Presented at Dermatology Summit 2021 LA JOLLA, Calif.–(BUSINESS NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin … Continue reading →
BioTech 365
JULY 6, 2021
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Leo taps X-Chem to discover anti-inflammatory dermatology drugs.Leo taps X-Chem to discover anti-inflammatory dermatology drugs ntaylor Tue, 07/06/2021 – 07:16 from FierceBiotech: Biotech [link].
BioTech 365
DECEMBER 3, 2020
DermTech Presents Updates in Precision Medicine at 2020 Dermatology Drug Development Summit DermTech Presents Updates in Precision Medicine at 2020 Dermatology Drug Development Summit LA JOLLA, Calif.–(BUSINESS –(BUSINESS WIRE)–DermTech, Inc.
BioTech 365
APRIL 22, 2021
Castle Biosciences Presents Data at the Dermatology Nurses’ Association 2021 Annual Convention Castle Biosciences Presents Data at the Dermatology Nurses’ Association 2021 Annual Convention FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #DNANurses–Castle Biosciences, Inc.
BioTech 365
MAY 20, 2021
Pyramid Biosciences Announces First Patients Dosed in Phase 1 Clinical Program for Dermatology Pyramid Biosciences Announces First Patients Dosed in Phase 1 Clinical Program for Dermatology PBI-100 is a topical treatment being developed for people living with mild to moderate … Continue reading →
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content